Clinical Trial Update: ALK33-001: A Study of RDC-0313 Administered to Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 study of RDC-0313 in healthy adults for alcohol dependence has completed, with Alkermes, Inc. as sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• RDC-0313

Snippet

Sponsor: Alkermes, Inc. | Conditions: Alcohol Dependence | Phase 1 | Status: COMPLETED